NCT04864405View on ClinicalTrials.gov

Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

PHASE4CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

September 5, 2022

Study Completion Date

July 29, 2023

Conditions
Breast Cancer
Interventions
OTHER

Morning administration of endocrine therapy

Endocrine therapy administered within one hour of patient wake up time

OTHER

Evening administration of endocrine therapy

Endocrine therapy administered within one hour of the patient bed time

Trial Locations (2)

Unknown

The Ottawa Hospital Cancer Centre, Ottawa

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER